Survivin expression and its potential clinical significance in gastrointestinal stromal sarcoma

International Immunopharmacology

Volumn 11, Issue 12, 2011, Pages 2227-2231

  Baykara, Meltem ^a   Akkus, Murat ^a   Yildiz, Ramazan ^a   Gonul, Ipek Isik ^a   Dursun, Ayse ^a   Coskun, Ugur ^a   Benekli, Mustafa ^a   Sevinc, Alper ^b   Dane, Faysal ^c   Buyukberber, Suleyman ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b GAZIANTEP UNIVERSITY   (Turkey)

^c MARMARA UNIVERSITY   (Turkey)

Author keywords

Anti apoptosis; Gastrointestinal stromal sarcoma; Inhibitors of apoptosis proteins; Survivin

Indexed keywords

SURVIVIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HUMAN; MALE; METASTASIS; MITOSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; TREATMENT FAILURE; TUMOR VOLUME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; HUMANS; INDOLES; INHIBITOR OF APOPTOSIS PROTEINS; MALE; MIDDLE AGED; MITOSIS; PIPERAZINES; PROGNOSIS; PYRIMIDINES; PYRROLES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 81855202019     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.10.005     Document Type: Article

References (40)

1. C.P. Raut, J.A. Morgan, and S.W. Ashley Current issues in gastrointestinal stromal tumors: incidence, molecular biology, and contemporary treatment of localized and advanced disease Curr Opin Gastroenterol 23 2007 149 158 (Pubitemid 46192969)
2. M. Miettinen, and J. Lasota Gastrointestinal stromal tumors: definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis Virchows Arch 438 2001 1 12 (Pubitemid 32128184)
3. U. De Giorgi, and J. Verweij Imatinib and gastrointestinal stromal tumors: where do we go from here? Mol Cancer Ther 4 2005 495 501 (Pubitemid 40443935)
4. C.D. Fletcher, J.J. Berman, C. Corless, F. Gorstein, J. Lasota, and B.J. Longley Diagnosis of gastrointestinal stromal tumors: a consensus approach Hum Pathol 33 2002 459 465 (Pubitemid 34747864)
5. S. Bauer, C.L. Corless, M.C. Heinrich, O. Dirsch, G. Antoch, and J. Kanja Response to imatinib mesylate of a gastrointestinal stromal tumor with very low expression of KIT Cancer Chemother Pharmacol 51 2003 261 265 (Pubitemid 36469957)
6. R.P. De Matteo, J.J. Lewis, D. Leung, S.S. Mudan, J.M. Woodruff, and M.F. Brennan Two hundred gastrointestinal stromal tumors: recurrence pattern and prognostic factors for survival Ann Surg 231 2000 51 58 (Pubitemid 30043939)
7. J.F. Graadt van Roggen, M.L. van Velthuysen, and P.C. Hogendoorn The histopathological differential diagnosis of gastrointestinal stromal tumours J Clin Pathol 54 2001 96 102
8. L.G. Kindblom, H.E. Remotti, F. Aldenborg, and J.M. Meis-Kindblom Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal Am J Pathol 152 1998 1259 1269 (Pubitemid 28221878)
9. B.P. Rubin, S. Singer, C. Tsao, A. Duensing, M.L. Lux, and R. Ruiz KIT activation is a ubiquitous feature of gastrointestinal stromal tumors Cancer Res 61 2001 8118 8121 (Pubitemid 33091601)
10. S. Hirota, A. Ohashi, T. Nishida, K. Isozaki, K. Kinoshita, and Y. Shinomura Gain-of-function mutations of platelet-derived growth factor receptor a gene in gastrointestinal stromal tumors Gastroenterology 125 2003 660 667 (Pubitemid 37070684)
11. P.C. Konturek, S.J. Konturek, P. Pierzchalski, W. Bielański, A. Duda, and K. Marlicz Cancerogenesis in Helicobacter pylori infected stomach-role of growth factors, apoptosis and cyclooxygenases Med Sci Monit 7 2001 1092 1107 (Pubitemid 32928637)
12. P.C. Konturek, S.J. Konturek, Z. Sulekova, H. Meixner, W. Bielanski, and T. Starzynska Expression of hepatocyte growth factor, transforming growth factor alpha, apoptosis related proteins Bax and Bcl-2, and gastrin in human gastric cancer Aliment Pharmacol Ther 15 2001 989 999 (Pubitemid 32578971)
13. M.E. Johnson, and E.W. Howerth Survivin: a bifunctional inhibitor of apoptosis protein Vet Pathol 41 2004 599 607 (Pubitemid 39573750)
14. M. Machtay, and B. Jeremic Complex and controversial issues in locally advanced non-small cell lung carcinoma Semin Surg Oncol 21 2003 128 137 (Pubitemid 37237422)
15. C. Sun, M. Cai, A.H. Gunasekera, R.P. Meadows, H. Wang, and J. Chen NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP Nature 401 1999 818 822
16. C. Adida, P.L. Crotty, J. McGrath, D. Berrebi, J. Diebold, and D.C. Altieri Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation Am J Pathol 152 1998 43 49 (Pubitemid 28028045)
17. A. Islam, H. Kageyama, N. Takada, T. Kawamoto, H. Takayasu, and E. Isogai High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma Oncogene 19 2000 617 623 (Pubitemid 30102912)
18. D.C. Altieri Validating survivin as a cancer therapeutic target Nat Rev Cancer 3 2003 46 54 (Pubitemid 37328886)
19. T. Ito, K. Shiraki, K. Sugimoto, T. Yamanaka, K. Fujikawa, and M. Ito Survivin promotes cell proliferation in human hepatocellular carcinoma Hepatology 31 2000 1080 1085 (Pubitemid 30233232)
20. H. Kawasaki, D.C. Altieri, C.D. Lu, M. Toyoda, T. Tenjo, and N. Tanigawa Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer Cancer Res 58 1998 5071 5074 (Pubitemid 28521163)
21. K. Tanaka, S. Iwamoto, G. Gon, T. Nohara, M. Iwamoto, and N. Tanigawa Expression of survivin and its relationship to loss of apoptosis in breast carcinomas Clin Cancer Res 6 2000 127 134 (Pubitemid 30064984)
22. M. Monzó, R. Rosell, E. Felip, J. Astudillo, J.J. Sánchez, and J. Maestre A novel antiapoptosis gene: reexpression of survivin messenger RNA as a prognosis marker in non-small cell lung cancers J Clin Oncol 17 1999 2100 2104 (Pubitemid 29318841)
23. J. Kato, Y. Kuwabara, M. Mitani, N. Shinoda, A. Sato, and T. Toyama Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy Int J Cancer 95 2001 92 95 (Pubitemid 32187079)
24. K.Y. Song, C.K. Jung, W.S. Park, and C.H. Park Expression of the antiapoptosis gene survivin predicts poor prognosis of stage III gastric adenocarcinoma Jpn J Clin Oncol 39 2009 290 296
25. B. Nachmias, Y. Ashhab, and D. Ben-Yehuda The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer Semin Cancer Biol 14 2004 231 243 (Pubitemid 38824584)
26. A.D. Schimmer Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice Cancer Res 64 2004 7183 7190 (Pubitemid 39372048)
27. A.W. Gramza, C.L. Corless, and M.C. Heinrich Resistance to tyrosine kinase inhibitors in gastrointestinal stromal tumors Clin Cancer Res 15 2009 7510 7518
28. T. Guo, M. Hajdu, N.P. Agaram, H. Shinoda, D. Veach, and B.D. Clarkson Mechanisms of sunitinib resistance in gastrointestinal stromal tumors harboring KITAY502-3ins mutation: an in vitro mutagenesis screen for drug resistance Clin Cancer Res 15 2009 6862 6870
29. Q.L. Deveraux, S.L. Schendel, and J.C. Reed IAP family proteins-suppressors of apoptosis Cardiol Clin 19 2001 57 74
30. P. Grabowski, T. Kühnel, F. Mühr-Wilkenshoff, B. Heine, H. Stein, and M. Höpfner Prognostic value of nuclear survivin expression in esophageal squamous cell carcinoma Br J Cancer 88 2003 115 119 (Pubitemid 36241227)
31. A. Martinez, B. Bellosillo, F. Bosch, A. Ferrer, S. Marcé, and N. Villamor Nuclear survivin expression in mantle cell lymphoma is associated with cell proliferation and survival Am J Pathol 164 2004 501 510 (Pubitemid 38364666)
32. S.M. Kennedy, L. O'Driscoll, R. Purcell, N. Fitz-Simons, E.W. McDermott, and A.D. Hill Prognostic importance of survivin in breast cancer Br J Cancer 88 2003 1077 1083 (Pubitemid 36560779)
33. K. Trieb, R. Lehner, T. Stulnig, I. Sulzbacher, and K.R. Shroyer Survivin expression in human osteosarcoma is a marker for survival Eur J Surg Oncol 29 2003 379 382 (Pubitemid 36675696)
34. T. Agui, D.J. McConkey, and N. Tanigawa Comparative study of various biological parameters, including expression of survivin, between primary and metastatic human colonic adenocarcinomas Anticancer Res 22 2002 1769 1776 (Pubitemid 34839194)
35. C. Cohen, C.M. Lohmann, G. Cotsonis, D. Lawson, and R. Santoianni Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis Mod Pathol 16 2003 574 583 (Pubitemid 36718439)
36. E. Okada, Y. Murai, K. Matsui, S. Isizawa, C. Cheng, and M. Masuda Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients Cancer Lett 163 2001 109 116 (Pubitemid 32121836)
37. M.A. Lee, G. Park, H.J. Lee, J.H. Jung, J.H. Kang, and Y.S. Hong Survivin expression and its clinical significance in pancreatic cancer BMC Cancer 5 2005 127
38. J. Fan, L. Wang, G.N. Jianga, W.X. Hea, and J.A. Ding The role of survivin on overall survival of non-small cell lung cancer, a meta-analysis of published literatures Lung Cancer 61 2008 91 96
39. T. Dohi, K. Okada, F. Xia, C.E. Wilford, T. Samuel, and K. Welsh An IAP-IAP complex inhibits apoptosis J Biol Chem 279 2004 34087 34090 (Pubitemid 39318028)
40. K. Asanuma, D. Kobayashi, D. Furuya, N. Tsuji, A. Yagihashi, and N. Watanabe A role for survivin in radioresistance of pancreatic cancer cells Jpn J Cancer Res 93 2002 1057 1062 (Pubitemid 35154273)